ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Zura Bio Ltd
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$3.81−0.07 (-1.80%)
Close on Oct 19, 2026
- Market cap
- $483.12M
- P/E (TTM)
- –
- Dividend yield
- –
Zura Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Zura Bio | Industry median |
|---|---|---|
| Market Cap | $365.11M | $166.30M |
| Enterprise Value | $159.98M | $88.19M |
Income (trailing twelve months)
| Measure | Zura Bio | Industry median |
|---|---|---|
| Operating Income | -$92.75M | -$21.40M |
| Pretax Income | -$85.82M | -$14.34M |
| Net Income | -$85.74M | -$22.46M |
| EBITDA | -$92.70M | -$16.91M |
| EPS (Diluted) | -$1.12 | -$0.83 |
Returns
| Measure | Zura Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -68.1% | -53.2% |
| Return on Assets (ROA) | -46.2% | -40.9% |
| Return on Invested Capital (ROIC) | -58.3% | -32.4% |
| Return on Capital Employed (ROCE) | -47.1% | -38.1% |
Balance sheet
| Measure | Zura Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $205.13M | $61.43M |
| Net Cash (Debt) | $205.13M | $15.35M |
| Net Cash Per Share | $2.14 | $0.66 |
| Working Capital | $194.18M | $76.81M |
Financial position
| Measure | Zura Bio | Industry median |
|---|---|---|
| Current Ratio | 12.90 | 3.34 |
| Quick Ratio | 12.57 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Zura Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$64.83M | -$12.35M |
| Capital Expenditures | -$112.97K | -$1.08M |
| Free Cash Flow | -$64.94M | -$20.22M |
| FCF Per Share | -$0.68 | -$0.42 |
Efficiency
| Measure | Zura Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$2.14M | -$703.34K |
| Employee Count | 40 | 74 |
Dividends and yields
| Measure | Zura Bio | Industry median |
|---|---|---|
| Earnings Yield | -23.5% | -23.3% |
| FCF Yield | -17.8% | -8.72% |
Shares
| Measure | Zura Bio | Industry median |
|---|---|---|
| Shares Outstanding | 95,829,100 | 58,127,000 |
| Shares Change (YoY) | 17.2% | 10.9% |
| Shares Change (QoQ) | 0.57% | 0.54% |
| Float | 57,303,800 | 49,136,700 |
| Shares Held by Insiders | 40.2% | 11.6% |
| Shares Held by Institutions | 76.1% | 59.4% |
Scores
| Measure | Zura Bio | Industry median |
|---|---|---|
| Altman Z-Score | 11.28 | -0.22 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Zura Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.